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Abstract
Purpose Non-severe nocturnal hypoglycemic events
(NSNHEs) are hypoglycemic events that occur during
sleep but do not require medical assistance from another
individual. This study was conducted to better understand
the NSNHEs as patients actually experience them in
their daily life, and how they impacted functioning and
well-being.
Methods Nine focus groups were held in four countries with
diabetics (Type 1 and Type 2) who had experienced an
NSNHE within the previous month: France (2 groups); Ger-
many (2 groups); United Kingdom (2 groups); and United
States (3 groups). These groups were audio-taped, translated
to English where applicable, and analyzed thematically.
Results Seventy-eight people with diabetes participated
in the focus groups: 41 (53 %) were female and 37 (47 %)
were male; 24 (31 %) had Type 1 diabetes, and 54 (69 %)
had Type 2 diabetes. Participant reports were grouped into
several major themes: next day effects, symptoms, sleep
impacts, social impacts, corrective action, practical man-
agement, feelings about NSNHEs, and work impacts.
Conclusions People with both Type 1 and Type 2 dia-
betes experience NSNHEs. The range of impact on these
patients is wide, from very mild to severe with a majority
of participants experiencing strong impacts that limit their
daily functioning. This finding suggests that NSNHEs are
more impactful than previously believed.
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Introduction
Hypoglycemia in general, including non-severe nocturnal
hypoglycemic events (NSNHEs), is a frequent complica-
tion of anti-diabetic medication. NSNHEs are rarely stud-
ied for their impacts on patient function or well-being and
may be misunderstood and underreported by healthcare
practitioners [1]. NSNHEs are hypoglycemic events that
occur during sleep but do not require medical assistance
from another individual. The patient is able to administer
corrective action upon awakening, although they may enlist
someone to assist for social support. In a recent survey of
6,756 adults with diabetes (including both Type 1 or Type
2 diabetics), 16.6 % of the sample reported having at least
one NSNHE in the previous month [2].
Research on NSNHEs is limited. A review of the liter-
ature reveals that the majority of research that has been
conducted has focused on either severe hypoglycemic
events during sleep, or laboratory-induced NSNHEs. The
conclusions drawn from these investigations are not gen-
eralizable to the everyday life of patients with diabetes.
There is a lack of data specific to how NSNHEs are
experienced by patients, and their impacts or conse-
quences. There is evidence of sleep-related hypoglycemia-
associated autonomic failure among those with Type 1
diabetes that result in a failure of the patient to awaken
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during hypoglycemia [3]. These researchers conclude that
this failure, coupled with imperfect glucose control, results
in a high frequency of NSNHEs. Additionally, studies have
found that study subjects are more susceptible to fatigue
and impacts on general well-being following NSNHEs
[4, 5].
Furthermore, research on the impacts on non-severe
hypoglycemic events generally (day or night) concludes
that non-severe hypoglycemia is associated with sub-
stantial negative economic consequences for both patients
and their employers, resulting from lost productivity and
missed work time. Productivity loss was highest for
NSNHEs that occurred during sleep [2]. Additionally,
quality of life decreases as the frequency and severity of
hypoglycemic events (day or night) increase [6].
Only a small number of studies have evaluated the
impact of NSNHEs on diabetes management, sleep quality,
daily functioning, productivity, well-being, and/or quality
of life in adults with diabetes [2–7]. In order to bridge this
gap in research, this qualitative study was conducted to
better understand the NSNHEs as patients actually expe-
rience them in their daily life. The concepts underlying this
paper are as follows: (1) patient functioning, which refers
to the patient’s day-to-day ability to accomplish their tasks;
(2) well-being, which refers to their psychological state;
and (3) patient perspective, which refers to how the patient
views their experience (of NSNHEs).
Using focus group interviews conducted in North Amer-
ica and Europe, the primary objective was to qualitatively
characterize and describe the experience of NSNHEs and
their impacts on patient functioning and well-being.
Methods
A qualitative design was chosen to meet the study objec-
tives, with semistructured focus group interviews conducted
in four countries (US, UK, Germany, and France) to gather
data on patient experience of NSNHEs. Focus group inter-
views are suited to this investigation because they help to
identify a ‘‘range of experiences and perspectives’’ as well
as provide a forum for both agreement and disagreement
between participants, which facilitates insight into the
variability of experience and the collection of disconfirming
evidence [8–10]. Additionally, four country sites were
chosen in order to provide an international perspective on
NSNHEs and to help mitigate any potential influences
specific to health systems or cultural orientations that might
affect the experience of NSNHEs. A purposive sampling
strategy was used. Participants were identified by profes-
sional market research organizations that recruit for and
host focus groups at their or their affiliates’ facilities in
each of the respective countries. The market research
organizations contacted individuals enrolled in their pro-
prietary databases and prequalified them by telephone using
a screening script. Participants received an honorarium for
their participation (equivalent to 125.00 USD). Each focus
group interview ranged from 8 to 11 participants. Each
participant received a copy of the informed consent form,
and signed documentation of consent was waived for this
study. Additionally, they were asked to complete a ques-
tionnaire developed specifically for this study for demo-
graphics and basic information about patient experience
with diabetes (e.g., their level of control of their diabetes,
the number of NSNHEs they experience, etc.). This project
was approved by an Institutional Review Board.
To be eligible for the study, participants were required to
be over the age of 18, read and speak the native language of
the country in which they reside, have a diagnosis of Type 1
or Type 2 diabetes, currently be using insulin, oral medi-
cations and/or Byetta (GLP-1) to treat their diabetes, and
have experienced an NSNHE within the past 3 months. For
the purposes of this study, an NSNHE was defined as having
typical hypo symptoms (such as shaking, sweating, hunger,
tremor, palpitations, confusion) that may or may not have
been confirmed by monitoring blood sugar, not having any
of the hypo symptoms but monitoring blood sugar showed
that it was too low (B70 mg/dl), or having symptoms but
not having low blood sugar. Participants were excluded
from this study if they were using an insulin pump.
All focus groups were moderated by professional focus
group leaders, and in the first language of the participants.
The focus groups were audio-taped, translated into English
where appropriate, and transcribed. The first author, who
has extensive professional experience in moderating focus
groups with patients, moderated the English-language
focus groups in the US and UK. Professional facilitators
moderated the focus group interviews in France and Ger-
many. The first author coached these moderators and
observed these groups with the aid of simultaneous trans-
lation to insure quality of discussion. The focus group
interviews were semistructured, and the interview guide
was designed to elicit participant experience with NSN-
HEs, their corrective action strategies, and the social and
practical impacts of these events on their lives.
The transcripts were analyzed thematically using qual-
itative analysis software ATLAS.ti, which was chosen for
its ability to handle and organize large data sets, provide
documentation of the coding process, and assist in orga-
nizing disconfirming evidence within the data set [11].
Descriptive coding was used to identify emerging concepts,
coded in the chronological order in which the focus groups
occurred. These codes were then aggregated into major
themes, also used in the Results section of this paper. This
coding method is consistent with grounded theory and
other thematic analysis methodologies and is well-suited to
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research on patient experiences [12, 13]. Each transcript
was skimmed once, coded, and reviewed. All transcripts
were reevaluated for new subthemes that emerged in sub-
sequent transcripts. The first two authors worked together
on the analysis, with the first contributing her experience of
conducting or attending all of the focus group interviews
and the second working primarily with the transcripts. Data
were triangulated between the literature, and each of the
two authors’ interpretations of patient statements. Thematic
saturation, defined as that point in time of the study where
no new themes or subthemes emerged, occurred by the 7th
focus group that was conducted. Data from subsequent
focus group interviews enriched the analysis with their
added descriptions of preexisting themes.
Results
Sample characteristics
Nine focus groups were conducted in the four countries
(cities included New York, Atlanta, Los Angeles, London,
Paris, and Frankfurt), totaling 78 participants (Table 1).
Forty-one (53 %) participants were female and 37 (47 %)
participants were male. Twenty-four (31 %) had Type 1
diabetes and 54 (69 %) had Type 2 diabetes. The mean age
of participants was 46.7 years (range: 20–65 years of age).
Type I participants were predominantly males (66.6 % of
the Type I group), while Type II participants were pre-
dominantly females (61.1 % of the Type II group).
The average duration of diabetes for the sample was
12 years (range: 1–44 years). Over half of the sample
considered their diabetes to be controlled well or very well
(51.3 %), and 34 participants (43.6 %) considered their
diabetes to be controlled moderately well. Both Type 1 and
Type 2 diabetics reported that they experienced NSNHEs:
Type 1 diabetics reported an average of 4.4 NSNHEs per
month (range: 1–22.5 per month) and Type 2 diabetics
reported an average of 3.8 NSNHEs per month (range:
1–12.5). The average incident rate of NSNHEs for both
groups combined was 4.0 per month (range: 1–22.5).
Ethnically and racially, nearly three quarters of the
participants in this study self-identified as White/Caucasian
(57 or 73.1 %). A majority of participants in this study
worked fulltime (62.8 %), and income was distributed
across all income categories.
Themes generated by focus groups
Experiencing NSNHEs
Both Type 1 and Type 2 diabetics experience NSNHEs.
Participants noted wide ranges of symptoms and severity of
NSNHEs. NSNHEs involved a constellation of symptoms
along a continuum ranging from unpleasant to traumatic,
with the most common symptom as sweating:
Samantha: What I wake up to is my hair is really,
really sweaty. My hands are dripping and my night
clothes are absolutely drenched and as soon as you
get up you have that chill. (London #1)
Participants noted anxiety or panic, shaking, and confusion
or disorientation. Here are three examples of impacts on
emotional states described by patients as typical symptoms
during an NSNHE:
Anxiety or panic
Florence: I think it’s also kind of like… for me,
anyway, it’s sort of like… it’s a shock and like
yourself, I kind of get the panic attack as well and then
I’ve got to calm myself down from that. (London #2)
Shaking
Male Speaker: I don’t have any palpitations, I am
very weak and shaking and I feel anxiety; I feel
oppressed because it is a situation that is outside your
control; each time we hope it’s going to be ok by
taking some sugary things, and each time is a sur-
prise. (Paris #2)
Confusion and disorientation
Devon: But the hardest part I find is that when I do
get up I’m so confused and I struggle with my speech
at times and all sorts, just to get thoughts together and
it leaves me drained for a day or two and then it’s
very hard to get back to normal life after an incident.
(London #1)
Additional symptoms included feeling hot or cold,
dizziness, heart pounding or palpitations, restlessness,
trouble with walking or balance, bad or weird dreams,
vision disturbances, headache, weakness, muscle tension,
neuropathy, anger, and nausea. The wide range of symp-
toms reported suggests that the experience of nocturnal
hypoglycemia is individualized.
When participants experienced NSNHEs, their correc-
tive action did not significantly differ from typical cor-
rective action taken for daytime hypoglycemic events.
Most participants reported eating or drinking something
sweet to raise their blood sugars. Although many partici-
pants noted that they check their blood sugar to confirm
hypoglycemia, some do not and respond instead to their
symptoms alone. Many participants reported that they kept
treatment food and drink on their bedside table so that it
was nearby in the event of an NSNHE.
Generally, participants reported having strong feelings
as a consequence of NSNHEs, and they emphasized fear
and worry the most:
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Male Speaker: It’s an interruption during the night,
it’s a decrease in the level, it’s a fear, a fear of
something that I don’t understand and cannot control.
(Paris #1)
Additional emotional consequences of NSNHEs included
frustration, anger, helplessness, and feelings of sadness.
Participants often compared and reported that the
experience of nocturnal hypoglycemia was different from
Table 1 Sample description
(n = 78)
a Blank response the participant
did not fill in this question
Type I Type II Total
(n = 24) (n = 54) (N = 78)
30.8 % 69.2 %
Gender; # (%)
Female 8 (33.3) 33 (61.1) 41 (52.6)
Male 16 (66.6) 21 (38.9) 37 (47.4)
Marital Status; # (%)
Single 9 (37.5) 15 (27.8) 24 (30.8)
Married 11 (45.8) 22 (40.7) 33 (42.3)
Partnered 2 (8.3) 10 (18.5) 12 (15.4)
Divorced 1 (4.2) 3 (5.6) 4 (5.1)
Widowed 1 (4.2) 4 (7.4) 5 (6.4)
Ethnicity; # (%)
White/White British/Caucasian 19 (79.2) 38 (70.4) 57 (73.1)
Black/African/African–American 4 (16.7) 7 (13.0) 11 (14.1)
Latino/Hispanic/Mexican–American 0 (0.0) 2 (3.7) 2 (2.6)
Asian 0 (0.0) 2 (3.7) 2 (2.6)
Mixed Race 0 (0.0) 3 (5.6) 3 (3.8)
Other 1 (4.2) 2 (3.7) 3 (3.8)
Age; mean (range) 40.4 (20–59) 50.0 (27–65) 46.7 (20–65)
Work Status; # (%)
Work full time for pay 16 (66.7) 33 (61.1) 49 (62.8)
Work part time for pay 2 (8.3) 10 (18.5) 12 (15.4)
Not working 5 (20.8) 10 (18.5) 15 (19.2)
Student 1 (4.2) 1 (1.9) 2 (2.6)
Education; # (%)
Grade school or less 1 (4.2) 1 (1.9) 2 (2.6)
High school or technical school 4 (16.7) 20 (37.0) 24 (30.8)
College 15 (62.5) 24 (44.4) 39 (50.0)
Graduate or professional school 4 (16.7) 9 (16.7) 13 (16.7)
Incomea; # (%)
Less than $40,000 9 (37.5) 16 (29.6) 25 (32.1)
$40,000–$60,000 5 (20.8) 15 (27.8) 20 (25.6)
Over $60,000 9 (37.5) 22 (40.7) 31 (39.7)
Blank responsea 1 (4.2) 1 (1.9) 2 (2.6)
Age when diagnosed; mean (range) 20.7 (1–46) 41.0 (17–62) 34.8 (1–62)
Length of time w/diabetes in years; mean (range) 19.7 (3–44) 8.5 (1–37) 12.0 (1–44)
NSNHE, times per month; mean (range) 4.4 (1–22.5) 3.8 (1–12.5) 4.0 (1–22.5)
(n = 53) (n = 77)
How well diabetes controlled; # (%)
Very well 1 (4.2) 3 (5.6) 4 (5.1)
Well 12 (50.0) 24 (44.4) 36 (46.2)
Moderately 9 (37.5) 25 (46.3) 34 (43.6)
Poorly 1 (4.2) 0 (0.0) 1 (1.3)
Very poorly 0 (0.0) 1 (1.9) 1 (1.3)
Blank responsea 1 (4.2) 1 (1.9) 2 (2.6)
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daytime hypoglycemia. They offered varied responses to
the differences between daytime and nighttime events;
however, the sentiment that NSNHEs are in some way
more difficult than daytime events was more common.
Sleep Impacts of NSNHEs
Although a few participants suspected that they do not
always awaken during an NSNHE, most participants stated
that nocturnal hypoglycemia caused them to wake up and
take corrective action.
The sleep impact data revealed a wide range of expe-
riences. Some individuals reported that it was easy for
them to get back to sleep. However, others reported that it
is very difficult to get back to sleep. Participants reported
that sleep was very generally disrupted:
Stephanie: I feel that way every night. Well, not that
I’m scared every night, but if I feel uncomfortable and
can’t fall asleep, then I’m worrying about it. (Atlanta)
Some people remained awake for the remainder of the night.
Of those individuals who reported an estimate of the time
they spent awake, the range was 5 min to 5 h. Individuals
also varied greatly in their tolerance to sleep disruption.
Generally, participants reported that NSNHEs disrupt
sleep, which amplifies the next day effects of the event.
There was a range of experience with regard to the severity
of the sleep disruption, from mild to severe.
Next day(s) effects of NSNHEs
The overall experience of the NSNHE was two-pronged,
leading to many discomforts the day following the event.
These discomforts the next day were the most frequent
major theme noted by participants. These effects were
caused by: (1) sleep disruption (and resulting sleep depri-
vation for some), in confluence with (2) physiological
effects of fluctuating blood sugars, in the night and
throughout the next day. Participants identified these
impacts and consequences as disruptive and often upsetting:
Carol: Yes, I feel low, very tired. Very tired. And
when I’m at work, I’m just counting down the hours
to go home. (London #2)
Khalid: Yes. It’s pretty much like having a really bad
hangover. It’s like you’ve gone out for a real session
for a drink one night, the next day you feel like
tired… that’s just how you feel, it’s like a really bad
hangover. (London #2)
Participants reported a wide range of consequences that
included feeling irritable, needing naps the next day, and an
inability to focus or concentrate the next day:
Irritation
Djamila: Irritation because that’s another night that is
broken up into 2 or 3 bits. I won’t feel very fresh in the
morning to go to work, so the irritation is more for the
next day because it won’t be very good. (Paris #2)
Needing naps
Richard: I’m fine once I’ve had my jam sandwich and
tea. The way I get round the tiredness bit is I have
catnaps. On the way to work, on the train, I might
doze off for about 10 min. On the way back home I
might doze off. (London #1)
Inability to focus or concentrate
Wildi: But sometimes I simply cannot comprehend it,
that I can’t concentrate, I think to myself, ‘‘It cannot
be that I’m not able to pull myself together for
5 min.’’ (Frankfurt #2)
There were only a very few participants who stated that
they did not feel particularly tired the following day, and these
participants also reported that they were not awake for very
long during an NSNHE. Likewise, there were a few incidences
of participant reports that they felt fine the next day, experi-
encing little impact from the event. This demonstrates (again)
the individuality and range of the experience of NSNHEs.
However, despite this disconfirming evidence, nearly all
commentary about next day effects of NSNHEs was neg-
ative. Other effects reported include lowered energy,
headaches, the need to sleep in late, awakening to high
blood sugars, moodiness, feeling down, nausea, anxiety,
and dizziness. In summary, NSNHEs cause a wide range of
negative consequences the day following the event that
include physiological symptoms, temporary cognitive
impacts, and emotional reactions.
Social impacts of NSNHEs
The most important consequence reported by participants
in all focus groups was that the NSNHE disturbed the sleep
of their bed partners, resulting in fatigue for them the
following day. All of these reports were of waking bed
partners during the night and as a result of an NSNHE:
Neil: But if it seems like more of a minor one but I’m
tossing and turning-waking up, even though some-
times I feel like she’s sleeping through it, she’ll say
she’s up and she’ll say she’s more tired than me. And
she’ll give me a guilt trip over it. ‘‘You could’ve been
quieter when you got up.’’ So she does care, but at the
same time, she’ll act like she’s more tired than even
me. It’s almost a guilt trip thing. (Los Angeles)
Participants also reported that they make an effort to avoid
waking bed partners. Here is an example:
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Farma: He panics. So I tend to try not to wake him up
or let him know what’s going on actually. He hates
that but that’s from over the years seeing how he
reacts. (New York)
Participants reported that they receive social support from
others who are knowledgeable about nocturnal hypoglyce-
mia, especially partners. Support in this context refers to
understanding, kindness, and general accommodation for
their NSNHE difficulties: social support. However, they
also reported that the day after an NSNHE, they have
reduced social interaction due to their fatigue levels and
general feelings of illness, and described their own social
withdrawal due to the event. More specifically, participants
stated that they cancel social events due to how they feel
after an NSNHE:
Respondent: I just wanted to say, when I’m not
feeling well I’m taking a different way home then I
go usually, I don’t like going through a particular
street, don’t ask me why, I don’t know it, but I don’t
like to go into a crowd of people when I don’t feel
well, so I prefer to go a longer way. And normally
I’m very spontaneous and if I get asked to go out after
work, then no, I can’t. […] it’s not because I don’t
want to see the person, I just don’t want to have
company. (Frankfurt #2)
Participants noted that their families were negatively
impacted by worry for the participant. Participants’ fatigue
also affected their interactions. Participants also noted that
sometimes they worried about their family:
Barbara: Because usually you spend time with your
kids, the homework, whatever we do, it’s a routine.
Sometimes I’m just too tired to even ask them how
their day was. I just come in and go straight to bed.
(New York)
Some participants regularly received assistance from others
in their households, even though they did not require this
assistance:
Victoria: I normally… I’m normally aware and I just
take myself, get myself a drink, but sometimes I’ll
have to because I panic from it. And I’ll wake him,
he’s great, he’ll go and get me a drink instead.
(London #2)
In summary, the strongest social impacts included
waking others up during an NSNHE and disrupting their
sleep, enlisting other’s support and assistance during
the event, and the experience of reduced social interac-
tion the following day by withdrawing or canceling
events.
Work impacts of NSNHEs
Impacts of NSNHEs on work mirror concerns reported on
next day effects of NSNHEs. Broadly, the tiredness and
fatigue from sleep disruption and the physiological effects
of fluctuating blood sugars contribute to many difficulties
at work. The most frequent impacts reported were prob-
lems with focus or concentration for work tasks, and
reduced productivity while at work. Additionally, partici-
pants reported that they call in sick, take extra breaks or
leave early, or go to work late in the morning. In summary,
NSNHEs have negative work impacts and lead to lost work
time.
Based on these findings from the qualitative data, a
preliminary theoretical model of the impact of NSNHEs
was developed, as shown in Fig. 1.
Discussion
NSNHEs were found to be disruptive and cause consider-
able distress to the majority of both Type 1 and Type 2
participants in this study. Among Type 2 diabetics, NSN-
HEs are not limited to those who are insulin-dependent.
These data also suggest that the range of individual expe-
rience of NSNHEs is very wide. However, for the majority
of participants, the continuum of experience ranges from
unpleasant to traumatic. The impacts on the individual’s
life and daily routine are equally wide-ranging, from
moderate to extreme. This is an important finding as pri-
mary care clinicians attending to patients with Type 2
diabetes may not appreciate the severity of the impacts and
potential consequences that NSNHEs have on their
patient’s functioning and well-being [1].
NSNHEs produce symptoms that awaken and frighten
people who experience them and sleep is often disrupted.
The day after the event is often a difficult day due to the
physiological effects of fluctuating blood sugars (during the
event and the following day) and sleep disruption or
deprivation. Next day effects are so uncomfortable that
they may be more disturbing to individuals than the
hypoglycemic event itself. NSNHEs are often thought to be
more difficult to predict, understand, or manage as com-
pared to daytime hypoglycemia, and patients are often
afraid or worry about their occurrence. Given the chal-
lenges of the symptoms and the emotionally laden expe-
rience of NSNHEs, participants wanted to avoid them if
possible. Some participants stated that they run their sugars
high before bedtime as a strategy for avoiding NSNHEs. It
is unclear whether this is on advice from their physicians or
diabetes educators. Potentially, keeping blood sugar high
can lead to other complications of diabetes over time.
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Although not a major theme in this data set, a few
participants reported that they were prone to falling during
their event due to dizziness and disorientation during
making this an interesting topic for further inquiry. Fur-
thermore, NSNHEs also have not inconsequential work
impacts of reduced productivity and lost work time for both
the person with diabetes as well as for some of their bed
partners. This echoes the conclusions drawn in a prior
study of the impacts of non-severe hypoglycemia, which
noted that productivity loss was highest for NSNHEs [2].
It is not surprising that participants recruited for their
experiences with NSNHEs would report that NSNHEs are
problematic for them, and findings of this study must be
placed within this context. However, previous research has
found that approximately 16 % of all persons with diabetes
experience at least one of these events in the previous
month. For this not insignificant percent of persons with
diabetes, this study does demonstrate that there are serious
negative impacts and consequences that are generally
unacknowledged in the literature. Further research is nee-
ded in this area in order to evaluate the level of concern this
poses for people with diabetes in general. Additionally, the
study found that NSNHEs are not only problematic for
those using insulin or only those with Type 1 diabetes.
As participants with Type 1 or Type 2 diabetes and
insulin and non-insulin users participated in the focus
group interviews together, it was not possible to
differentiate the experiences of NSNHEs between these
two forms of diabetes or treatments conclusively. It is
possible that the frequency, severity, and personal reactions
may differ between Type 1 and Type 2 diabetics or treat-
ments. In these focus group interviews, there suggestion
that participants who had Type 1 diabetes and, therefore,
typically had a longer tenure with insulin use and its
titration were slightly less bothered by NSNHEs due to
familiarity with them. For these individuals, the NSNHE
experience entailed similar impacts and consequences
physically, but it is possible they were less worried or
fearful of them. Future research in this area may illuminate
diabetes type-specific moderators for the overall impacts of
NSNHEs.
Study limitations include translation and transcription
problems for those focus group interviews held in a lan-
guage other than English as it was difficult for the trans-
lators to relate nuances and the full intent of the focus
group discussion. This resulted in less description than
would occur within the first language. Despite these dis-
crepancies, the data yielded insights that were quite rich in
understanding the impact of NSNHEs on these participants.
Additional qualitative and quantitative research is nee-
ded to understand the phenomenon of NSNHEs from a
physiological, emotional, and social perspective. These
data indicate that NSNHEs are not always experienced in
the same way as hypoglycemia occurring during the day.
Fig. 1 Preliminary Theoretical
Model
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Research that explicitly investigates NSNHEs may alter
diabetes management strategies overall and lead to new
recommendations for the practical and daily management
of hypoglycemia.
Finally, this study did not explore the experiences of
patients with their healthcare providers about NSNHEs in
depth. However, a few participants suggested that physi-
cians may not appreciate the impacts of NSNHEs on
patients. In contrast, some participants reported discussing
NSNHEs with their doctor and receiving helpful advice.
Given the role of physicians and other clinicians in
directing diabetes management, it is important to know
what influence they may be having on the management and
treatment of NSNHEs. Given the substantial negative
impacts reported in this study, it would be of concern if
health care providers as well as patients do not fully
understand these NSNHE impacts. The study findings
warrant further research on physicians’ views on NSNHE
impacts.
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